000			03310nam a22003495i 4500
999			_c80172 _d80172 _x1
001			80172
003			ES-MaUEC
005			20230207040255.0
006			a||||fo||||\00|\0
007			cr\nn\nnnaamaa
008			131106s2014 xxu| s |||| 0|eng d
020			_a9781461482024
024	7		_a10.1007/978-1-4614-8202-4 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aK3601 _b2014 EB
100	1		_aBrougher, Joanna T. _988134 _0Local _eautor
245	1	0	_aIntellectual Property and Health Technologies : _bBalancing Innovation and the Public's Health _cby Joanna T. Brougher
260			_aNew York, NY _bSpringer New York _c2014
300			_a1 recurso en línea (XV, 214 páginas) _b8 ilustraciones
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
520			_aIntellectual Property and Health Technologies Balancing Innovation and the Public's Health Â{u02AF}anna T. Brougher, Esq., MPH At first glance, ownership of intellectual property seems straightforward: the control over an invention or idea. But with the recent explosion of new scientific discoveries poised to transform public health and healthcare systems, costly and lengthy patent disputes threaten both to undermine the attempts to develop new medical technologies and to keep potentially life-saving treatments from patients who need them. Â{u026E}tellectual Property and Health Technologies grounds readers in patent law and explores how scientific research and enterprise are evolving in response. Geared specifically to the medical disciplines, it differentiates among different forms of legal protection for inventors such as patents, copyrights, trademarks and trade secrets, explains their limitations, and argues for balance between competing forces of exclusivity and availability. Chapters delve into the major legal controversies concerning medical and biotechnologies (deleted "in terms of pricing, markets, and especially the tension between innovation and access"), including: The patent-eligibility of genes The patent-eligibility of medical process patents The rights and roles of universities and inventors The balancing of access, innovation, and profit in drug development The tension between biologics, small-molecule drugs, and their generic counterparts International patent law and access to medicine in the developing world Â{u0073} these issues continue to shape and define the debate, Intellectual Property and Health Technologies enables professionals and graduate students in public health, health policy, healthcare administration, and medicine to understand patent law and how it affects the development of medical technology and the delivery of medicine.
988			_aEBOOK, EBSPRINGER
650		7	_9669942 _aMedicina _2embne _xDerecho
710	2		_aSpringerLink (Online service) _0Local _9106996
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4614-8202-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12879253 _b10-10-17 _c11-11-15
942			_2lcc _cLE
945			_aRA1-1270 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i1155907x _z06-04-17
998			_b09/2020 _dz _ea